Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ceribell, Inc.CBLL · Entity 4994 | Director | June 02, 2026 | June 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ceribell, Inc.
Report date June 02, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,284 |
Reported balance
After 2026-06-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-02 · Grant · Acquired 7,838 · Balance 23,284 F1: Represents restricted stock units ("RSUs"). F2: Includes 23,284 RSUs held directly by the Reporting Person. 15,446 RSUs were previously reported as being held indirectly through the Josef Parvizi Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Josef Parvizi Trust | 707,206 |
Reported balance
Holding disclosure · report date 2026-06-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 707,206 F3: The shares reported as indirectly owned by the Josef Parvizi Trust no longer include 15,446 RSUs. Such RSUs were previously reported as being held through the trust but are held directly by the Reporting Person. F4: The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities. F5: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Innovation ACP Trust | 907,911 |
Reported balance
Holding disclosure · report date 2026-06-02 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 907,911 F5: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. F6: The Reporting Person is a co-trustee of the Innovation ACP Trust, and therefore may be deemed to share beneficial ownership of these securities. |
| Common StockSEC Table I · non-derivative | IndirectBy ACP 2021 Trust | 369,088 |
Reported balance
Holding disclosure · report date 2026-06-02 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 369,088 F5: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. F7: The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs").
F2: Includes 23,284 RSUs held directly by the Reporting Person. 15,446 RSUs were previously reported as being held indirectly through the Josef Parvizi Trust.
F3: The shares reported as indirectly owned by the Josef Parvizi Trust no longer include 15,446 RSUs. Such RSUs were previously reported as being held through the trust but are held directly by the Reporting Person.
F4: The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities.
F5: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F6: The Reporting Person is a co-trustee of the Innovation ACP Trust, and therefore may be deemed to share beneficial ownership of these securities.
F7: The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2026 Filed Jun 4, 2026 21:37 UTC | Ceribell, Inc. CBLL · Entity 4994 | GrantCommon Stock | 7,838 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-257810 · ownership.xml · nonDerivative · entry 1 Parvizi Josef · CIK 0002038244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,284 F1 · shares: Represents restricted stock units ("RSUs"). F2 · balance_after: Includes 23,284 RSUs held directly by the Reporting Person. 15,446 RSUs were previously reported as being held indirectly through the Josef Parvizi Trust. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 17:07 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 16,714 | $20.27 | $338,792.78 |
DisclosureSEC source: 0001193125-26-063161 · ownership.xml · nonDerivative · entry 1 Parvizi Josef · CIK 0002038244 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Josef Parvizi Trust Disclosed balance after: 722,652 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20 to $20.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 21:17 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 6,986 | $20.00 | $139,720.00 |
DisclosureSEC source: 0001193125-26-059447 · ownership.xml · nonDerivative · entry 2 Parvizi Josef · CIK 0002038244 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Josef Parvizi Trust Disclosed balance after: 739,366 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20 to $20.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:17 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 1,300 | $20.00 | $26,000.00 |
DisclosureSEC source: 0001193125-26-059447 · ownership.xml · nonDerivative · entry 1 Parvizi Josef · CIK 0002038244 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Josef Parvizi Trust Disclosed balance after: 746,352 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2025. F2 · ownership.nature: The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 15, 2026 Filed Jan 20, 2026 21:52 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 25,000 | $22.94 | $573,500.00 |
DisclosureSEC source: 0001193125-26-016743 · ownership.xml · nonDerivative · entry 1 Parvizi Josef · CIK 0002038244 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Josef Parvizi Trust Disclosed balance after: 747,652 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.43 to $23.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities. F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 01:07 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 25,000 | $21.49 | $537,250.00 |
DisclosureSEC source: 0001193125-25-323313 · ownership.xml · nonDerivative · entry 1 Parvizi Josef · CIK 0002038244 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Josef Parvizi Trust Disclosed balance after: 772,652 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21 to $21.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities. F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 01:00 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 25,000 | $20.26 | $506,500.00 |
DisclosureSEC source: 0001193125-25-314647 · ownership.xml · nonDerivative · entry 1 Parvizi Josef · CIK 0002038244 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Josef Parvizi Trust Disclosed balance after: 797,652 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20 to $20.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities. F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 10, 2025 Filed Jun 17, 2025 23:49 UTC | Ceribell, Inc. CBLL · Entity 4994 | GrantCommon Stock | 8,828 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-087600 · ownership.xml · nonDerivative · entry 1 Parvizi Josef · CIK 0002038244 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Josef Parvizi Trust Disclosed balance after: 822,652 F1 · shares: Represents 8,828 restricted stock units. F2 · ownership.direct: These securities were inadvertently reported as directly held by the Reporting Person in previous Form 3 and Form 4 filings. F3 · ownership.nature: The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities. F6 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| October 15, 2024 Filed Oct 16, 2024 20:17 UTC | Ceribell, Inc. CBLL · Entity 4994 | ConversionSeries C-1 Preferred Stock · Derivative | 152,775 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-115005 · ownership.xml · derivative · entry 5 Parvizi Josef · CIK 0002038244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 152,775 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each share of the issuer's Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately prior to the closing of the issuer's initial public offering on October 15, 2024 and had no expiration date. F6 · derivative.exercise_date: Each share of the issuer's Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately prior to the closing of the issuer's initial public offering on October 15, 2024 and had no expiration date. F6 · derivative.expiration_date: Each share of the issuer's Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately prior to the closing of the issuer's initial public offering on October 15, 2024 and had no expiration date. Read SEC document |
| October 15, 2024 Filed Oct 16, 2024 20:17 UTC | Ceribell, Inc. CBLL · Entity 4994 | ConversionCommon Stock | 152,775 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-115005 · ownership.xml · nonDerivative · entry 4 Parvizi Josef · CIK 0002038244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 813,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Each share of the issuer's Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately prior to the closing of the issuer's initial public offering on October 15, 2024 and had no expiration date. F2 · balance_after: Includes 6,618 RSUs. Read SEC document |
| October 11, 2024 Filed Oct 16, 2024 20:17 UTC | Ceribell, Inc. CBLL · Entity 4994 | GrantCommon Stock | 6,618 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-115005 · ownership.xml · nonDerivative · entry 1 Parvizi Josef · CIK 0002038244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 661,049 F1 · shares: Represents 6,618 restricted stock units ("RSUs"). F2 · balance_after: Includes 6,618 RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.